IJGC Podcast

IJGC Podcast

Download on the App Store

IJGC Podcast episodes

  • JAVELIN 100 & 200 Trials with Bradley Monk
    Dr. Bradley Monk is a member of Arizona Oncology and part of the US Oncology Network and continues to practice in Phoenix. Most recently, he has been appointed the US Oncology Medical Director of Gynecologic Oncology Research. Dr. Monk is also a Professor on the Clinical Scholar Track at the University of Arizona College of Medicine – Phoenix and works at Arizona Oncology (US Oncology Network).

    Dr. Monk’s research interests include the prevention and treatment of gynecologic cancers. Dr. Monk is a fellow of the American College of Surgeons, the American College of Obstetricians and Gynecologists) and the American Society for Colposcopy and Cervical Pathology, as well as being an active member of the Society of Gynecologic Oncology, International Gynecologic Cancer Society, and American Society of Clinical Oncology. He has authored more than 330 peer-reviewed articles along with more than 30 book chapters dealing predominantly with the prevention and chemotherapy of gynecologic malignancies and patient quality of life.

    42 min
  • ConCerv Trial with Kathleen Schmeler
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Kathleen Schmeler to discuss the ConCerv Trial. Dr. Schmeler is the lead author of ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer, which is the Lead Article of IJGC’s October 2021 issue. Dr. Schmeler is a Professor in Gynecologic Oncology at The University of Texas MD Anderson Cancer Center. She provides care to women with gynecologic malignancies including surgery, chemotherapy and preventive services. Dr. Schmeler is also the Executive Director of Global Oncology for the MD Anderson Cancer Network. Her research interest is in cervical cancer prevention and treatment, particularly for resource-constrained countries and medically underserved communities in the US.
    ( https://ijgc.bmj.com/content/early/2021/09/06/ijgc-2021-002921.share )
    @kmschmeler @MDAndersonNews
    Highlights:
    •The ConCerv trial is the first prospective study of conservative surgery in women with low-risk cervical cancer. It included 14 sites in 9 countries.
    •Findings from the ConCerv Trial offer prospective data supporting a more conservative approach to low-risk patients, sparing them the early and late morbidity associated with radical procedures.
    •It will also allow for safer cervical cancer surgery in low- and middle-income countries, where the burden of cervical cancer is highest.
    •In the our study, conservative surgery was associated with a 3.5% recurrence rate in women with low-risk cervical cancer. In addition, the rate of positive lymph nodes was 5%, with lymph node assessment recommended in this low-risk population.

    •Further study is needed to determine long term outcomes and optimal pathologic criteria for conservative surgery."

    49 min
  • The Mentor’s Podcast with Christina Fotopoulou
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou for another installment of the Mentor’s Podcast. Professor Fotopoulou works at the Department of Surgery and Cancer at Imperial College London, UK. She is an elected ESGO council member and Chair of the ESGO guidelines committee.
    Christina Fotopoulou (@CF_PC_OvCaGroup / @HopkinsMedNews)
    Highlights:
    - Early support from mentors and "giants" in the field, national and international networking and early focusing/specialization in the field of interest are keys to success
    - Try to turn your weaknesses and failures to learning points and opportunities to make you stronger

    - Hard work, kindness and caring for patients, team spirit, professionalism and dedication are the main keys of success next to any talent and luck that anyone might be fortunate enough to have

    39 min
  • Role of hysterectomy in stage IVB uterine cancer with Yuefeng Wang and Matthew Ballo
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Yuefeng Wang and Matthew Ballo to discuss role of hysterectomy in stage IVB uterine cancer. Dr. Yuefeng Wang is a radiation oncologist and Dr. Matthew Ballo is a radiation oncologist, and the Chair of the Department of Radiation Oncology, West Cancer Center and Research Institute, Memphis, TN.
    Yuefeng Wang and Matthew Ballo (@YuefengWang2 / @west_cancer)
    Highlights:
    -For uterine cancer with pelvic/abdomen metastasis, there is survival benefit associated with total abdominal hysterectomy, in addition to systemic therapy. However, we do not know if there is any role of total abdominal hysterectomy for patient with distant organ metastasis.

    -In this retrospective, hypothesis-generating study including 3,200 uterine cancer patients with distant organ metastasis, total abdominal hysterectomy plus chemotherapy was associated with significant longer survival (19.8 vs 11.0 months, p

    27 min
  • Racial Disparities in Endometrial Cancer Screening with Ultrasound with Kemi Doll
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Kemi Doll to discuss racial disparities in endometrial cancer screening with ultrasound. Dr. Kemi Doll is a gynecologic oncologist, health services researcher, and Associate Professor at the University of Washington, Department of Obstetrics and Gynecology. Her expertise is in Black-White disparities in endometrial cancer outcomes in the United States.

    Kemi Doll (@kemidoll / @uwmedicine / @uwashobgyn)

    33 min
  • ENDO3 Trial with Andreas Obermair
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andreas Obermair to discuss the ENDO3 Trial. Dr. Obermair is a gynaecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes.
    Highlights
    •ENDO3 exemplifies the need to question current standard clinical practice if this practice – while performed routinely - has not shown patient benefit.
    •ENDO3 employs meticulous methodology and has been designed with input from gynaecological oncologists, medical and radiation oncologists, behavioural scientists, exercise physiologists, statisticians, translational scientists, including the patient perspective.
    •ENDO3 will offer unique insights into clinically meaningful outcomes that will shape our approach to surgical treatment of endometrial cancer in the future.

    Andreas Obermair (@AndreasObermair / @UQ_gynae_cancer)

    38 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.

More shows like IJGC Podcast

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

36 Listeners

BJSM Podcast by BMJ Group

BJSM Podcast

47 Listeners

DTB Podcast by BMJ Group

DTB Podcast

4 Listeners

Gut Podcast by BMJ Group

Gut Podcast

7 Listeners

Sharp Scratch by The BMJ

Sharp Scratch

5 Listeners

ADC Podcast by BMJ Group

ADC Podcast

3 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

4 Listeners

STI Podcast by BMJ Group

STI Podcast

3 Listeners

JNNP Podcast by BMJ Group

JNNP Podcast

9 Listeners

Heart Podcast by BMJ Group

Heart Podcast

40 Listeners

JNIS Podcast by BMJ Group

JNIS Podcast

14 Listeners

EBN Podcast by BMJ Group

EBN Podcast

1 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

51 Listeners

FG Podcast by BMJ Group

FG Podcast

0 Listeners

Medical Humanities Podcast by BMJ Group

Medical Humanities Podcast

6 Listeners

Lupus Science and Medicine Podcast by BMJ Group

Lupus Science and Medicine Podcast

15 Listeners

RMD Open Podcast by BMJ Group

RMD Open Podcast

3 Listeners

BMJ Best Practice Podcast by BMJ Group

BMJ Best Practice Podcast

28 Listeners

BMJ Future Health Podcast by BMJ Publishing Group

BMJ Future Health Podcast

0 Listeners